Treatment Persistence and Adherence with Overactive Bladder Medications in Taiwan: A Retrospective Database Analysis [PDF]
European Urology Open ScienceBackground: Overactive bladder (OAB) is commonly treated with mirabegron or antimuscarinics, but real-world evidence on treatment persistence, adherence, and fall/fracture outcomes in Taiwan remains limited.
Shiau-Han Chen +2 more
doaj +2 more sources
Use of Antimuscarinics in the Elderly
The Scientific World Journal, 2009 Overactive bladder (OAB) is a common, costly, and treatable condition in older persons. There is a wide array of available antimuscarinics for the treatment of these conditions; however, their side effect profile and the limited number of studies that ...
Bhavin Patel +2 more
doaj +4 more sources
Protective Effects of Antimuscarinics on the Bladder Remodeling After Bladder Outlet Obstruction
Cellular Physiology and Biochemistry, 2017 Background/Aims: Overactive bladder associated with bladder outlet obstruction (BOO) is a highly prevalent condition, which is usually treated with antimuscarinics.
Kunjie Wang, Banghua Liao, De-Yi Luo
exaly +3 more sources
A Retrospective Database Analysis of Anticholinergic Burden Among Older Patients With and Without Overactive Bladder in South Korea [PDF]
International Neurourology JournalPurpose This study aimed to measure the cumulative anticholinergic burden in older outpatients in South Korea with and without newly started overactive bladder (OAB) medications, and to assess the contribution OAB treatment-related antimuscarinics have ...
Kyu-Sung Lee +7 more
doaj +2 more sources
Comparisons of urinary bladder responses to common antimuscarinics reveals unique effects of darifenacin [PDF]
Frontiers in PhysiologyIntroductionAntimuscarinics are the first-line pharmaceutical treatment for overactive bladder (OAB). However, some literature suggests that responses to these antimuscarinics can influence a variety of non-muscarinic receptors.
Vineesha Veer +2 more
doaj +2 more sources
Scientific Reports, 2021 The association between bladder antimuscarinic use and dementia development is unclear. We used data from the Taiwan National Health Insurance Research Database to determine the association between the exposure dose and duration of bladder ...
Tomor Harnod +5 more
doaj +1 more source
Adverse event assessment of antimuscarinics for treating overactive bladder: a network meta-analytic approach. [PDF]
PLoS ONE, 2011 BACKGROUND: Overactive bladder (OAB) affects the lives of millions of people worldwide and antimuscarinics are the pharmacological treatment of choice.
Thomas M Kessler +6 more
doaj +1 more source
Biomedicines, 2023 Major depressive disorder is one of the most severe mental disorders. It strongly impairs daily functioning, and, in extreme cases, it can lead to suicide.
Paweł Moćko +4 more
doaj +1 more source
Mirabegron and Anticholinergics in the Treatment of Overactive Bladder Syndrome: A Meta-analysis
Revista Brasileira de Ginecologia e Obstetrícia, 2023 Objective To compare the use of mirabegron with anticholinergics drugs for the treatment of overactive bladder (OB). Data Source Systematic searches were conducted in EMBASE, PUBMED, Cochrane, and LILACS databases from inception to September 2021.
Luisa Gracio Ferreira Sartori +6 more
doaj +1 more source
Treatment of bladder dysfunction with solifenacin: is there a risk of dementia or cognitive impairment? [PDF]
Brazilian Journal of Medical and Biological Research, 2022 The use of bladder antimuscarinics is very common in the elderly. However, recent population-based studies that assessed the use of anticholinergics or bladder antimuscarinics showed an increased risk of dementia when these drugs were used for a ...
L.P. Dantas +8 more
doaj +1 more source